Xiamen, China, Oct. 11, 2024 (GLOBE NEWSWIRE) -- (“Star Fashion” or the “Company”) today announced the pricing on October 10 ...

The company’s upsized offering is a hopeful sign for venture investors in the sector.

CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, ...

The gross proceeds to Upstream from the initial public offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $255.0 million.

CeriBell announced that it priced an upsized initial public offering (IPO), expecting proceeds of approximately $180.3 ...

Nordic Capital is exploring options for Swedish digital payments company Trustly Group AB including a potential sale or ...

Ceribell Inc., a medical-device maker that uses artificial intelligence to monitor patient seizures, was on track for a ...

CAMP4 Therapeutics Corporation ("CAMP4") (Nasdaq: CAMP), a clinical-stage biotechnology company developing a pipeline of regulatory RNA-targeting therapeutics ...

Launch Two Acquisition Corp. (the “Company”) announced today the closing of its initial public offering of 23,000,000 units, which includes 3,000,000 units issued pursuant to the exercise by the ...

Ceribell Inc. launched its initial public offering of more than 10.6 million shares of common stock at $17 and steadily saw ...

CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression ...

Upstream Bio (UPB) shares rallied 32% Friday following the asthma drug developer’s $255M upsized initial public offering. Read more here.